20 LATEST RESOURCES (19 INDEXED)
Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · September 2018
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · March 2018
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
Treatment Patterns, Health Care Resource Utilization, and Costs in Japanese Adults with Attention-Deficit Hyperactivity Disorder Treated with Atomoxetine · February 2018
Multimedia (Interviews-Research)
Neuropsychiatric Disease and Treatment
A Comparison of the Clinical Effectiveness and Cost of Specialised Individually Delivered Parent Training for Preschool Attention-Deficit/Hyperactivity Disorder and a Generic, Group-Based Programme: A Multi-Centre, Randomised Controlled Trial of the New Forest Parenting Programme versus Incredible Years · October 2017
Articles
European Child and Adolescent Psychiatry
A Cost-Effectiveness Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder in the UK · January 2017
Articles
European Journal of Health Economics
Comparative Treatment Patterns, Healthcare Resource Utilization and Costs of Atomoxetine and Long-Acting Methylphenidate among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Germany · November 2016
Articles
European Journal of Health Economics
Comparative Cost Analysis of Sequential, Adaptive, Behavioral, Pharmacological, and Combined Treatments for Childhood ADHD · January 2016
Articles (Manuscripts-Versions)
PubMed Central>Journal of Clinical Child and Adolescent Psychology
Costs and Treatment Patterns of Incident ADHD Patients: A Comparative Analysis Before and After the Initial Diagnosis · December 2015
Articles
Health Economics Review
Cost-Utility Analysis of Methylphenidate Treatment for Children and Adolescents with ADHD in Brazil · September 2015
Articles
Brazilian Journal of Psychiatry
Use of Services and Associated Costs for Young Adults with Childhood Hyperactivity/Conduct Problems: 20-Year Follow-Up · June 2014
Articles
British Journal of Psychiatry
The Prevalence and Incidence, Resource Use and Financial Costs of Treating People with Attention Deficit/Hyperactivity Disorder (ADHD) in the United Kingdom (1998 to 2010) · October 2013
Articles
Child and Adolescent Psychiatry and Mental Health
Societal Costs and Quality of Life of Children Suffering from Attention Deficient Hyperactivity Disorder (ADHD) · May 2007
Articles
European Child and Adolescent Psychiatry
A Systematic Review and Economic Model of the Effectiveness and Cost-Effectiveness of Methylphenidate, Dexamfetamine and Atomoxetine for the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents · July 2006
Publications (Books-Reports)
National Institute for Health Research
A Comparison of Service Use and Costs among Adults with ADHD and Adults with Other Chronic Diseases · December 2005
Articles
Psychiatric Services
Relative Efficacy of School-Home Notes with and without Response Cost in Impoverished Elementary Students with Attention-Deficit/Hyperactivity Disorder · November 2002
Theses-Dissertations
Louisiana State University
Health Care Use and Costs for Children with Attention-Deficit/Hyperactivity Disorder: National Estimates from the Medical Expenditure Panel Survey · May 2002
Articles
JAMA Pediatrics
Use and Costs of Medical Care for Children and Adolescents with and without Attention-Deficit/Hyperactivity Disorder · January 2001
Articles
Journal of the American Medical Association